Comparison of effects of 2 local anaesthetics 0.5 percent levobupivacaine heavy versus 0.5 percent bupivacaine heavy in patients undergoing transurethral resection of prostate under spinal anaesthesia.

Comparison of effects of 0.5 percent levobupivacaine heavy versus 0.5 percent bupivacaine heavy in patients undergoing transurethral resection of prostate under spinal anaesthesia - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/05/067965

Enrollment

Registered

2024-05-28

Start date

Unknown

Completion date

Unknown

Last updated

2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N40- Benign prostatic hyperplasia

Interventions

Intervention1: 0.5% Levobupivacaine heavy : 2 ml of 0.5% Levobupivacaine heavy administered in spinal anaesthesia Control Intervention1: 0.5% bupivacaine heavy: 2 ml 0.5% bupivacaine heavy administer

Eligibility

Inclusion criteria

Inclusion criteria: Patients undergoing transurethral resection of prostate with BMI of 18-30 kg/m2 who are ASA I, II, III.

Exclusion criteria

Exclusion criteria: a) Unable to follow simple commands b) Raised Intracranial pressure c) Infection at the site of administration d) Hypersensitivity to local anaesthetic f) Coagulopathy e) Sepsis f) Uncorrected hypovolemia

Design outcomes

Primary

Measure	Time frame
a) Time taken for onset of sensory and motor blockade b) Time taken to achieve a maximum sensory level c) Time taken for 2-segment regression d) Time taken for sensory and motor recoveryTimepoint: Level of sensory and motor block at 2,4,6,8,10,15,20,25,30,40,50 and 60 minutes from administration of spinal anesthesia	—

Secondary

Measure	Time frame
a) Hemodynamic changes b) Frequency of adverse eventsTimepoint: Hemodynamic changes at 2,4,6,8,10,15,20,25,30,40,50 and 60 minutes from administration of spinal anesthesia	—

Countries

India

Contacts

Public ContactDr Samyukta Sankaran

Kasturba Medical College, Manipal

drlaxmishenoy@gmail.com9448911261

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026